Literature DB >> 1239084

Maduromycosis (Madura foot) in Kentucky.

A Warintarawej, W G Winter, N L Goodman.   

Abstract

The first case of proven maduromycosis originating in the state of Kentucky, and the 21st case reported in the United States, is described. The disease, which involved the foot, was caused by Monosporium apiospermum. The importance of suspecting and culturing for fungal organisms in cases of chronic or recurrent infections of the extremities is stressed. The method of treatment was experimental; whether true cure was accomplished may not be known for years. Although many fungi, including Monosporium apiospermum, are relatively resistant to all forms of chemotherapy, some types of fungi readily respond to easily administered antibiotics. Specific fungal identification by trained mycologists is important in all cases of mycetoma.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1239084     DOI: 10.1097/00007611-197512000-00025

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

Review 1.  Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review.

Authors:  Z A Kanafani; Y Comair; S S Kanj
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-19       Impact factor: 3.267

Review 2.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 3.  Mycetoma: Development of Diagnosis and Treatment.

Authors:  Xingpei Hao; Marcus Cognetti; Rhonda Burch-Smith; Emerald O'Sullivan Mejia; Gene Mirkin
Journal:  J Fungi (Basel)       Date:  2022-07-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.